Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., R.A.).
Department of Cardiology, Sussex Cardiac Centre, Brighton and Sussex University Hospitals, United Kingdom (J.C., D.H.-S.).
Circ Cardiovasc Interv. 2018 Oct;11(10):e006436. doi: 10.1161/CIRCINTERVENTIONS.118.006436.
Enabling strategies (ESs) are increasingly used during percutaneous coronary intervention for chronic total occlusive disease (CTO-PCI), enhancing procedural success. Using the British Cardiovascular Society dataset, we examined changes in the use of ESs and procedural/clinical outcomes for CTO-PCI.
ESs were defined as intravascular ultrasound, rotational/laser atherectomy, dual arterial access, use of microcatheters, penetration catheters or CrossBoss, and procedures categorized by number of ESs used. Data were analysed on all elective CTO-PCI procedures performed in England and Wales between 2006 and 2014. Multivariable logistic regression was used to identify predictors of procedural success. During 28 050 CTO-PCIs, there were significant temporal increases in ES use. There was a stepwise increase in CTO success with increased ES use, with 83.8% of cases successful where ≥3 ESs were used. Overall, CTO-PCI success rate for the whole cohort increased from 55.4% in 2006 to 66.9% in 2014 ( P<0.001), but the greatest increase in procedural success was associated with ≥3 ES use. In multivariable analysis, any ES use and the number of ESs used were predictive of procedural success. Coronary perforation increased from 1.2% with zero ES use to 4.0% with ≥3 ( P<0.001). After adjustment, although arterial complication, in-hospital bleeding, in-hospital mortality, and major adverse cardiovascular or cerebrovascular events remained more likely with ES use, 30-day mortality was not significantly different between groups.
ES use during CTO-PCI was associated with significant improvements in CTO-PCI success. ES use was associated with increased procedural complications and in-hospital major adverse cardiovascular events, but not with 30-day mortality.
在慢性完全闭塞性病变经皮冠状动脉介入治疗(CTO-PCI)中,越来越多地使用辅助技术(ESs)以提高手术成功率。我们利用英国心血管学会的数据,研究了 CTO-PCI 中 ESs 的使用变化及其与手术/临床结局的关系。
ESs 定义为血管内超声、旋磨/激光斑块切除术、双动脉入路、使用微导管、穿透导管或 CrossBoss,根据使用的 ESs 数量对手术进行分类。对 2006 年至 2014 年期间在英格兰和威尔士进行的所有择期 CTO-PCI 手术进行数据分析。采用多变量逻辑回归分析确定手术成功的预测因素。在 28050 例 CTO-PCI 中,ES 的使用呈明显的时间性增加。随着 ES 使用的增加,CTO 成功率呈阶梯式增加,≥3 个 ES 使用率达到 83.8%。总的来说,整个队列的 CTO-PCI 成功率从 2006 年的 55.4%上升到 2014 年的 66.9%(P<0.001),但与手术成功率显著增加相关的是≥3 个 ES 的使用。在多变量分析中,任何 ES 的使用和 ES 的使用数量都是手术成功的预测因素。冠状动脉穿孔的发生率从 0 个 ES 使用率的 1.2%上升到≥3 个 ES 使用率的 4.0%(P<0.001)。调整后,虽然 ES 的使用与动脉并发症、院内出血、院内死亡率和主要心血管或脑血管不良事件的发生风险增加有关,但各组之间 30 天死亡率无显著差异。
CTO-PCI 中 ES 的使用与 CTO-PCI 成功率的显著提高有关。ES 的使用与手术并发症和院内主要心血管不良事件的增加有关,但与 30 天死亡率无关。